Leaders in the Drug Repositioning and Repurposing Field to Meet for 6th Annual Drug Repositioning Conference in Chicago in June 2017
Minneapolis, MN (PRWEB) May 01, 2017 -- Arrowhead Publishers is pleased to announce that the 6th Annual Drug Repositioning, Repurposing and Rescue Conference will be taking place June 27-28, 2017 in Chicago, IL. This event will provide a platform for a variety of stakeholders furthering drug development through a variety of collaborations, including patient advocacy efforts and industry/academic/government cooperation. For more information, visit: http://www.drugrepositioningconference.com/index/download-brochure.
This year’s conference will be focused on the use of repurposing to find and develop new therapies for rare diseases. Several key themes at this event will include
• Patient Advocacy Efforts: Emphasis on and engagement with patient advocacy groups, who are investigating in drug repositioning efforts to an unprecedented degree
• New Partnerships: The conference will explore how new partnerships between various groups, including government, industry and academia are teaming up to advance repurposing efforts
• Commercial Case Studies: Leaders in drug repositioning will discuss their successes, failures and the way forward
• Collaborative efforts: Government/academic/industry collaborations will be explored and highlighted in order to determine how disparate groups can achieve success
• Systematic Repositioning and Data Analytics: Repurposing is no longer based on serendipity as more and more companies are designing tools to streamline and increase the odds of success
Featured Speakers Include:
• Ronald Alfa, MD, Ph.D., Vice President, Discovery and Product, Recursion Pharmaceuticals
• Bobbie Ann Austin, Ph.D., Program Officer, Drug Development Partnership Programs, National Center for Advancing Translational Sciences (NCATS), Office of the Director, National Institutes of Health
• Pieter Dylst, Senior Manager Market Access and Value Added Medicines, Medicines for Europe
• Laura Kleiman, Ph.D., Scientific Research Director, cBio Center, Dana-Farber Cancer Institute
• Daphna Laifenfeld, Ph.D., Sr. Director, Personalized & Predictive Medicine, Teva Pharmaceutical Industries
• Kevin Pan, Ph.D., Chief Executive Officer, Asieris Pharmaceuticals
• Aris Persidis, Ph.D., President, Biovista
• Michael Pollastri, Ph.D., Associate Professor & Chair, Northeastern University, College of Science
• Vidula Sukhatme, Founder and CEO, Global Cures
Please visit http://www.drugrepositioningconference.com/index/speakers for the full speaking faculty.
For more information, please contact:
John Waslif: Managing Director
Arrowhead Publishers
866-945-0263 ext 700
john.waslif(at)arrowheadpublishers.com
Rachel Donlon: Marketing Associate
Arrowhead Publishers
866-945-0263 ext 701
rachel.donlon(at)arrowheadpublishers.com
Rachel Donlon, Arrowhead Publishers and Conferences, +1 (952) 807-6819, [email protected]
Share this article